Hers has launched a menopause and perimenopause specialty offering personalized treatment plans through licensed providers.
Approximately 1.3 million women in the United States experience menopause each year, but only about 30% of OB/GYN residency programs provide formal menopause training. Women spend an average of nine years in poor health, which is 25% more than men.
“This isn’t just about medication – it’s about building and growing a platform that women can trust to access the care they need. Women have been navigating an outdated healthcare system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms,” said Dr. Jessica Shepherd, Chief Medical Officer of Hers. “I’ve been an OB/GYN for more than 20 years, and I know that transforming the healthcare experience for women starts with increasing access to providers who are trained specifically in caring for women at every life stage. As one of the largest digital health platforms, we can help change the way women experience healthcare and thrive.”
Treatment plans for eligible customers may include prescription medication in pill, patch, or cream forms. Treatments may include estradiol to help alleviate symptoms such as hot flashes and night sweats, and progesterone to protect the uterine lining and improve sleep quality. Care is directed by independent licensed providers trained in perimenopause and menopause care. The company expects to introduce additional treatment options in 2026.
The service is not available in all 50 US states at this point in time and requires a prescription. Hormone replacement therapies are prescribed off-label at a healthcare provider’s discretion.
